ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 165

New Insights Into The Metabolic Origin Of Osteoarthritis

Ignacio Rego-Pérez1, María Eugenia Vázquez-Mosquera2, Angel Soto-Hermida2, Mercedes Fernández-Moreno2, Juan Fernández-Tajes2, Estefanía Cortés-Pereira2, Sara Relaño-Fernández2, Natividad Oreiro-Villar2, Carlos Fernández-López2 and Francisco J. Blanco3,4,5, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 2INIBIC-Hospital Universitario A Coruña. Rheumatology Division. Genomic Group, A Coruña, Spain, 3INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 4CIBER-BBN-ISCIII, Madrid, Spain, 5Proteo-Red/ISCIII, Madrid, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Gene Expression, genomics, metabolic syndrome and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Metabolic alterations take place in osteoarthritis (OA) and the mtDNA haplogorups influence the prevalence and severity of the disease. The aim of this work is to analyze the metabolic behavior in OA from different points of view, including the analysis of gene polymorphisms, mitochondrial variants and gene expression.

Methods:

The first approach consisted in the analysis of the influence of the mtDNA haplogroups in the body mass index (BMI) in a cohort of 638 OA patients and 474 healthy controls from Spain. This approach was followed by a second one that included the analysis of the expression levels of genes related to both lipid and glucose metabolism in RNA isolated from 24 OA and 22 healthy normal (N) cartilage samples; for this purpose we also used the chondrocyte cell line TC28a2 in order to analyse the glucose overload (at 1, 4.5 and 18 g/l) during 48 hours in the expression levels of these genes as well as of both MMP-3 and  IL-6; finally, we search for possible interactions between the mtDNA haplogroups and the SNP -866C/T (rs659366) in the promoter region of UCP2 to assess their incidence in the prevalence of OA in a cohort of 137 OA patients and 133 healthy controls from Spain. Nucleic acid isolation was carried out using commercial kits following the manufacturer recommendations with some modifications. Appropriate data analysis was performed with SPSS software (v19) and qBase plus software (Biogazelle).

Results: The mtDNA haplogroup J and OA are independently associated with BMI, so that carriers of this mitochondrial variant show significant lower BMI values (p=0.006) meanwhile OA patients show significant higher values (p<0.001), being the BMI a risk factor for OA.  The obtained OA/N expression ratio of GLUT1 (0.8±0.26), GLUT3 (0.73±0.01), GLUT5 (0.68±0.19), HK1 (1.09±0.02), HK2 (1.59±0.21), INSR (0.99±0.08), CPT1B (1.30±0.1), ACADM (2.65±0.36), HADHB (1.68±0.09), PPARg (0.61±0.11), PPARa (1.41±0.33) did not show significant differences (p > 0.05). However, a significant increased expression of UCP2 (3.86±0.12) as well as a decreased expression of PDK4 (0.20 ±0.01) was detected in OA cartilage samples (p<0.05). Gene expression of OLR-1 was only observed in OA cartilage samples. The experiments of glucose overload carried out in the cell line TC28a2 showed a direct correlation between glucose concentration and the expression levels of UCP2 (correlation coefficient (c.c)=0.965; p=0.102), MMP-3 (c.c=0.992; p=0.08) and IL-6 (c.c=0.996; p=0.05) as well as an inverse correlation with PDK4 (c.c= - 0.914; p=0.265). The analysis of the interaction between the mtDNA haplogroups and the SNP rs659366 showed that carriers of both haplogroups J or T (mtDNA cluster TJ) that also carry the T allele of rs659366 have a significant decreased risk of OA (OR=0.581; CI: 0.357 – 0.948; p=0.029).

Conclusion:

            This work provides strong evidence on metabolic alterations that occur in OA. These alterations involve the lipid and glucose metabolism, through the mitochondrial pathway, as well as the switch that modulates the balance between both metabolisms which, in turn, would lead to the increased inflammatory process that takes place in OA.


Disclosure:

I. Rego-Pérez,
None;

M. E. Vázquez-Mosquera,
None;

A. Soto-Hermida,
None;

M. Fernández-Moreno,
None;

J. Fernández-Tajes,
None;

E. Cortés-Pereira,
None;

S. Relaño-Fernández,
None;

N. Oreiro-Villar,
None;

C. Fernández-López,
None;

F. J. Blanco,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/new-insights-into-the-metabolic-origin-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology